Johnson & Johnson: Changing health for humanity

Popular pages

• Johnson & Johnson: Changing the Trajectory of Health for Humanity | Johnson & Johnson

  For over 135 years, we have maintained a tradition of quality and innovation. Learn about the products, people and history that make up Johnson & Johnson.

• Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to

  Investigational CD20-targeted CAR-Ts Enhance Janssen’s B-cell Malignancy PortfolioAgreement Deepens Janssen’s Leadership in Oncology and Hematology, and Accelerates Commitment to Delivering Transforma...

• Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

  th Annual Global Healthcare Conference Johnson & Johnson to Participate in the Goldman Sachs 44 th Annual Global Healthcare Conference New Brunswick, NJ (May 10, 2023) - Johnson & Johnson (NYSE: JNJ) ...

• First Phase 3 TREMFYA® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction

  Late-breaking data from the Phase 3 QUASAR Induction Study show statistically significant and clinically meaningful improvements among ulcerative colitis patients, including bio-naïve patients and tho...

• Using Data Science to Get New Treatments to Patients Faster

  Johnson & Johnson's Sid Jain uses artificial intelligence to accelerate IBD clinical trials, aiming to bring new treatments to patients like himself.

• What Are Clinical Trials? | Johnson & Johnson

  Learn about the key aspects of clinical trials, the different clinical trial phases and the importance of clinical trial diversity.